Open original FDA record ↗Recall record
- FDA identifier
- Z-1887-2019
- Company in FDA record
- AtriCure, Inc.
- FDA record creation date
- Jun 26, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The sterile package seal for the Epi-Sense Guided Coagulation System may be compromised, and has a worst-case reasonable harm of infection if used.
Source facts
- Action
- On May 29, 2019, the firm notified customers of the recall via Urgent Advisory Notice. Customers were asked to take the following actions: " Immediately quarantine any affected product as identified within this Advisory Notice. " Contact AtriCure product complaints by phone at 1-866-349-2342 (select option 6) or e-mail to pcomplaints@atricure.com to request a Return Goods Authorization (RGA). " Return the attached Acknowledgement Form. See Attachment B. The acknowledgement form must be completed and returned even if product is not on hand by selecting the second option. " Adverse reactions or quality problems experienced with the use of this product may be reported to the FDAs MedWatch Adverse Event Reporting program either online, by regular mail or by fax. If you have any questions, please contact Rob Cantu, Vice President of Quality at (1-513-644-4245) from 9-6pm ET on Mondays - Fridays. You may also contact customer service at (1-866-349-2342) any time of day, your message will be forwarded to Quality Assurance for review promptly. This advisory issue will also be posted on AtriCures website at www.atricure.com/products.
- Initiated
- 2019-05-29
- Root cause
- Process control
- Terminated
- 2020-05-04
- Distribution
- Worldwide distribution - US Nationwide distribution, and countries of Germany and Netherlands.
- Recall number
- Z-1887-2019
- Recall status
- Terminated
- CDRH record ID
- 173344
- FDA record created
- 2019-06-26
- Recall event number
- 83021